Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes
Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover,...
Saved in:
Published in | Journal of pharmaceutical investigation Vol. 50; no. 1; pp. 1 - 16 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Singapore
01.01.2020
한국약제학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2093-5552 2093-6214 |
DOI | 10.1007/s40005-019-00429-z |
Cover
Abstract | Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands. |
---|---|
AbstractList | Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands. KCI Citation Count: 7 Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and development. These physiological effects of vitamin D are mediated by activation of the transcription factor vitamin D receptor (VDR). Moreover, vitamin D is closely related to several pathological conditions including osteoporosis, secondary hyperparathyroidism, cancer, psoriasis and autoimmune diseases, which is not only due to calcemic but also non-calcemic effects of vitamin D such as cell proliferation, differentiation, and immunomodulation. These various abilities of vitamin D have made VDR an attractive therapeutic target. Already, numerous vitamin D analogs have been developed and studied in in vitro disease models or animal models, and some have been in clinical trials or approved for the treatment of certain diseases. In addition, the transcriptional and/or post-transcriptional regulation by VDR activation also affects the genes involved in drug metabolism and disposition, possibly leading to pharmacokinetic changes of several drugs in clinical use. This review provides a detailed summary of therapeutic targets of VDR ligands, and their effects on the transporters and metabolic enzymes, causing in vitro and in vivo pharmacokinetic changes of several drugs. The clinical research is further required for the confirming the clinical relevance of pharmacokinetic drug interactions by VDR ligands. |
Author | Maeng, Han-Joo Choi, Min Sik Kim, Yu Chul |
Author_xml | – sequence: 1 givenname: Min Sik surname: Choi fullname: Choi, Min Sik organization: Lab of Pharmacology, College of Pharmacy, Dongduk Women’s University – sequence: 2 givenname: Yu Chul surname: Kim fullname: Kim, Yu Chul email: yckim@inje.ac.kr organization: Department of Pharmaceutical Engineering, Inje University – sequence: 3 givenname: Han-Joo surname: Maeng fullname: Maeng, Han-Joo email: hjmaeng@gachon.ac.kr organization: College of Pharmacy, Gachon University |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552342$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kLtu3DAQRYnABuI4_gFXbF0o4UOipNKw8zBgIECwPTFLDXfplUiB5AbY_YH8dijLVQo3c6e4Z4A5n8iFDx4JueXsC2es_ZpqxlhTMd5XjNWir84fyJVgvayU4PXF2940jfhIblJ6YUtd8a7rr8jfzR4jzHjMztAMcYc50WDpH5dhcp4-0ogG5xwiHd0O_JBoGTTv0UU67yFOYMLBeVx4tBZN4bcnOoXhOEJ2wS_XcgSf5hAzxpWfMMM2jAvjz6cJ02dyaWFMePOW12Tz_dvm4Wf1_OvH08P9c2WkaHI1AAjVKs7Bbo2FrhuwFzUHaZSAvhuMrU3bMokdGmk63qqtbK2sTaOgaUBek7v1rI9WH4zTAdxr7oI-RH3_e_OklSpSW1m63do1MaQU0WpTpCwvlXfcqDnTi3696tdFv37Vr88FFf-hc3QTxNP7kFyhVMp-h1G_hGP0xcZ71D93HZ5L |
CitedBy_id | crossref_primary_10_3390_pharmaceutics12111129 crossref_primary_10_1007_s40005_023_00659_2 crossref_primary_10_3390_ijms24098166 crossref_primary_10_3390_pharmaceutics12030264 crossref_primary_10_1007_s40005_022_00563_1 crossref_primary_10_1007_s40005_022_00600_z crossref_primary_10_1016_j_ejps_2023_106396 crossref_primary_10_1007_s40005_021_00538_8 crossref_primary_10_3390_genes14010193 |
Cites_doi | 10.1056/NEJM197205182862009 10.1001/jama.281.16.1505 10.1159/000322008 10.1210/er.2001-8002 10.1001/archopht.120.5.607 10.1210/endo.143.7.8887 10.1002/jps.22366 10.1016/S0006-291X(02)02742-0 10.2133/dmpk.DMPK-11-RG-089 10.1210/jc.2008-0784 10.3389/fonc.2014.00125 10.1210/endo-108-3-1083 10.1002/bdd.1856 10.1172/JCI114229 10.1073/pnas.202471299 10.1002/jbmr.256 10.1093/ndt/gfh329 10.4161/cc.23846 10.1111/j.1365-2133.1989.tb01353.x 10.1016/j.chembiol.2013.12.016 10.1159/000346846 10.4161/cc.24445 10.1182/blood-2002-07-1984 10.1053/j.gastro.2011.11.040 10.1124/dmd.113.055673 10.1002/jnr.490370212 10.1161/STROKEAHA.107.513655 10.1016/S0960-0760(99)00112-0 10.1007/s11060-007-9418-z 10.1097/PPO.0b013e3181c51ee6 10.1002/jcb.10346 10.1111/j.1753-4887.2008.00105.x 10.1016/j.bcp.2006.04.033 10.1016/j.jsbmb.2010.03.053 10.1016/S0022-2143(99)90004-5 10.1016/j.ejps.2009.01.006 10.1002/ijc.26279 10.1007/s10620-010-1544-3 10.1248/bpb.b15-00356 10.1002/cncr.25059 10.1046/j.1365-2133.1999.02975.x 10.1016/0272-6386(95)90455-7 10.3390/nu5072502 10.1002/jcb.22661 10.1124/mol.51.5.741 10.1124/mol.65.3.720 10.1111/j.1600-0625.2007.00570.x 10.1053/gast.1996.v110.pm8613068 10.1210/endo.143.5.8777 10.1111/j.1432-1033.1995.tb20727.x 10.3346/jkms.2012.27.9.1037 10.1124/dmd.116.070300 10.3389/fphys.2014.00213 10.1053/ajkd.1998.v32.pm9808145 10.1210/endo.139.3.5770 10.1038/sj.jid.5700692 10.1111/1523-1747.ep12480255 10.1016/j.jsbmb.2013.02.005 10.1074/jbc.M308430200 10.1074/jbc.M010101200 10.1111/ijd.12790 10.1007/s00246-012-0199-6 10.1124/jpet.108.149815 10.1182/blood.V93.7.2225 10.1592/phco.29.6.691 10.1016/S0090-4295(97)00408-1 10.1210/me.2011-1109 10.1093/jnci/89.3.182 10.1016/0006-2952(92)90405-8 10.1007/s10157-005-0363-x 10.1016/j.jsbmb.2006.12.098 10.1007/s00774-006-0738-4 10.1111/j.1365-2133.1996.tb07608.x 10.1046/j.1365-2133.2001.04075.x 10.1177/1352458513494959 10.1124/jpet.107.127209 10.1016/j.jsbmb.2005.06.002 10.1016/S0021-9258(18)61537-6 10.1038/bjc.1997.501 10.1172/JCI113010 10.1074/jbc.M201323200 10.1007/s00198-008-0650-y 10.1093/ajcn/79.3.362 10.1210/endo.133.6.8243296 10.1124/mol.110.068403 10.1007/BF01623386 10.1002/bdd.682 10.1093/ndt/17.suppl_10.41 10.1093/carcin/bgh332 10.1016/j.ejps.2012.02.018 10.1124/jpet.111.179101 10.1159/000420143 10.1046/j.1523-1755.1999.055003821.x 10.3389/fphys.2014.00122 10.1093/jnci/95.12.896 10.1177/1756285612447090 10.1046/j.1523-1755.2003.00029.x 10.1053/ajkd.2003.50097 10.1194/jlr.M044420 10.3899/jrheum.111594 10.1159/000371350 10.1681/ASN.V981427 10.1124/mol.60.6.1399 10.1093/ajcn/83.4.754 10.1002/jps.24195 10.1210/endo.141.6.7515 10.4161/cc.5.4.2467 10.1002/bdd.742 10.1046/j.1523-1755.1999.00575.x 10.1093/carcin/bgm094 10.1007/s00198-003-1570-5 10.1016/0006-291X(91)91333-8 10.1016/S0022-5347(01)63098-2 10.1038/clpt.2008.165 10.1111/j.1774-9987.2004.00191.x 10.4161/derm.17534 10.1016/j.jneuroim.2015.01.005 10.1152/ajpendo.00224.2004 10.1111/j.1523-1755.2004.00432.x 10.1159/000323941 10.1124/mol.105.020792 10.1097/01.ASN.0000093255.56474.B4 10.1016/j.jsbmb.2006.12.099 10.1124/mol.105.019851 10.1001/archopht.122.9.1357 10.1111/j.1472-8206.2011.00944.x 10.1038/nrrheum.2010.86 10.1158/1535-7163.373.3.3 10.1007/s003930070034 10.1124/mol.112.077909 10.1053/j.ajkd.2004.01.012 10.1158/1535-7163.MCT-09-0064 10.1046/j.1365-2133.2002.04567.x 10.1016/j.trsl.2016.07.006 10.1038/onc.2008.88 10.1093/jn/133.7.2425S 10.1158/0008-5472.CAN-08-2307 10.1126/science.1070477 10.1002/cncr.25478 10.1111/j.0022-202X.2004.22424.x 10.1002/bdd.694 10.1359/JBMR.050605 10.4161/cbt.7.3.5418 10.1111/j.1365-2133.1988.tb03204.x 10.1002/bdd.2118 10.2147/TCRM.S3552 10.1074/jbc.M411520200 10.1111/j.1600-0625.2004.00257.x 10.1161/01.RES.87.3.214 10.1093/ndt/17.suppl_10.28 10.1161/CIRCULATIONAHA.107.706127 10.1016/j.ejps.2012.11.008 10.1556/EuJMI.3.2013.4.1 10.1016/j.jsbmb.2006.12.081 10.1016/0140-6736(91)92157-W 10.1016/S0303-7207(00)00226-4 10.1074/jbc.M311052200 |
ContentType | Journal Article |
Copyright | The Korean Society of Pharmaceutical Sciences and Technology 2019 |
Copyright_xml | – notice: The Korean Society of Pharmaceutical Sciences and Technology 2019 |
DBID | AAYXX CITATION ACYCR |
DOI | 10.1007/s40005-019-00429-z |
DatabaseName | CrossRef Korean Citation Index |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-6214 |
EndPage | 16 |
ExternalDocumentID | oai_kci_go_kr_ARTI_6600773 10_1007_s40005_019_00429_z |
GrantInformation_xml | – fundername: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning grantid: NRF-2016R1D1A1B03931470 |
GroupedDBID | -EM .UV 06D 0R~ 0VY 203 29~ 30V 4.4 406 408 96X 9ZL AAAVM AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAZMS ABAKF ABDZT ABECU ABFTV ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABTEG ABTHY ABTKH ABTMW ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACKNC ACMLO ACOKC ACPIV ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEMSY AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKLTO AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AUKKA AXYYD BGNMA CSCUP DNIVK DPUIP EBLON EBS EIOEI EJD ESBYG FERAY FIGPU FINBP FNLPD FRP FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 HMJXF HRMNR HZ~ I0C IKXTQ IWAJR IXD J-C JBSCW JDI JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O9J PT4 RLLFE ROL RSV S3A SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE TSG U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW Z7U Z87 ZMTXR ZOVNA ~A9 AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ACYCR |
ID | FETCH-LOGICAL-c325t-daa267611afbcfa88de9241a3c62a98dcf4c7703e8ec3c8176b37f34c56a55a3 |
IEDL.DBID | AGYKE |
ISSN | 2093-5552 |
IngestDate | Sun Mar 09 07:51:16 EDT 2025 Tue Jul 01 01:09:53 EDT 2025 Thu Apr 24 23:00:14 EDT 2025 Fri Feb 21 02:37:05 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Vitamin D receptor (VDR) Transporters Vitamin D Pharmacokinetics Metabolic enzymes Therapeutic target |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c325t-daa267611afbcfa88de9241a3c62a98dcf4c7703e8ec3c8176b37f34c56a55a3 |
PageCount | 16 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_6600773 crossref_citationtrail_10_1007_s40005_019_00429_z crossref_primary_10_1007_s40005_019_00429_z springer_journals_10_1007_s40005_019_00429_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20200100 2020-01-00 2020-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 1 year: 2020 text: 20200100 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Journal of pharmaceutical investigation |
PublicationTitleAbbrev | J. Pharm. Investig |
PublicationYear | 2020 |
Publisher | Springer Singapore 한국약제학회 |
Publisher_xml | – name: Springer Singapore – name: 한국약제학회 |
References | Fujioka, Hasegawa, Ishikura, Matsushita, Sato, Tanji (CR51) 1998; 160 Shapira, Agmon-Levin, Shoenfeld (CR137) 2010; 6 Wang, Pencina, Booth, Jacques, Ingelsson, Lanier, Benjamin, D’Agostino, Wolf, Vasan (CR159) 2008; 117 Pilz, März, Wellnitz, Seelhorst, Fahrleitner-Pammer, Dimai, Boehm, Dobnig (CR122) 2008; 93 Nishizawa, Morii, Ogura, De Luca (CR111) 1991; 90 Holick, Chen, Kong, Sanan (CR64) 1996; 1 Getzenberg, Light, Lapco, Konety, Nangia, Acierno, Dhir, Shurin, Day, Trump, Johnson (CR53) 1997; 50 Goto, Komaba, Fukagawa (CR55) 2008; 1 Yoon, Son, Kim, Choi, Maeng (CR169) 2015; 38 van Ginkel, Yang, Marcet, Chow, Kulkarni, Darjatmoko, Lindstrom, Lokken, Bhattacharya, Albert (CR154) 2007; 85 Kota, Abdul, Allen, Kalagara, Roufogalis (CR72) 2012; 26 Shedeed (CR138) 2012; 33 Drocourt, Ourlin, Pascussi, Maurel, Vilarem (CR42) 2002; 277 Meyer, Goetsch, Pike (CR98) 2012; 26 Pilz, Dobnig, Fischer, Wellnitz, Seelhorst, Boehm, März (CR121) 2008; 39 Kumagai, O’Kelly, Said, Koeffler (CR76) 2003; 95 Eloranta, Hiller, Jüttner, Kullak-Ublick (CR47) 2012; 82 Wang, Wang, Shen, Overholser, Cooper, Lu, Tang, Zhou, Sun, Zhong, Favus, Decker, Liu, Peng (CR160) 2016; 178 Yudoh, Matsuno, Kimura (CR170) 1999; 133 Chow, Durk, Maeng, Pang (CR31) 2013; 34 Nakagawa, Kawaura, Kato, Takeda, Okano (CR105) 2005; 26 DeLuca, Bedale, Binkley, Gallagher, Bolognese, Peacock, Aloia, Clagett-Dame, Plum (CR40) 2011; 26 Cheng, Fang, Kim, Krausz, Tanaka, Chiang, Gonzalez (CR25) 2014; 55 Grostern, Bryar, Zimbric, Darjatmoko, Lissauer, Lindstrom, Lokken, Strugnell, Albert (CR56) 2002; 120 Slatopolsky, Cozzolino, Lu, Finch, Dusso, Staniforth, Wein, Webster (CR142) 2003; 63 Chow, Sun, Khan, Groothuis, Pang (CR28) 2010; 31 Ke, Qi, Crawford, Simmons, Xu, Li, Plum, Clagett-Dame, DeLuca, Thompson, Brown (CR69) 2005; 20 Naveh-Many, Silver (CR107) 1993; 133 Slatopolsky, Finch, Ritter, Denda, Morrissey, Brown, DeLuca (CR141) 1995; 26 Trémezaygues, Reichrath (CR151) 2011; 3 McCarthy, Li, Sinal (CR96) 2005; 280 Shevde, Plum, Clagett-Dame, Yamamoto, Pike, DeLuca (CR139) 2002; 99 Mantell, Owens, Bundred, Mawer, Canfield (CR91) 2000; 87 Bener, Ehlayel, Tulic, Hamid (CR13) 2012; 157 Bhatia, Saini, Shen, Bi, Qiu, Weigel, Falzon (CR15) 2009; 8 Aguilera, Peña, García, Larriba, Ordóñez-Morán, Navarro, Barbáchano, López de Silanes, Ballestar, Fraga, Esteller, Gamallo, Bonilla, González-Sancho, Muñoz (CR3) 2007; 28 Trump, Deeb, Johnson (CR152) 2010; 16 Monier-Faugere, Geng, Friedler, Qi, Kubodera, Slatopolsky, Malluche (CR102) 1999; 55 Zierold, Mings, Deluca (CR174) 2006; 69 Coburn, Maung, Elangovan, Germain, Lindberg, Sprague, Williams, Bishop (CR33) 2004; 43 Hayashi, Tsuchiya, Itaya, Takenaka, Kobayashi, Yoshizawa, Nakamura, Monkawa, Ichihara (CR61) 2004; 19 Thummel, Brimer, Yasuda, Thottassery, Senn, Lin, Ishizuka, Kharasch, Schuetz, Schuetz (CR149) 2001; 60 Wang, Jones, Studzinski (CR158) 1996; 56 Zhuang, Burnstein (CR173) 1998; 139 Miao, Liu, Wang, Meng, Guo, Sun, Peng, Ma, Kaku, Liu (CR99) 2013; 48 Hara, Kusuzaki, Takeshita, Kuzuhara, Tsuji, Ashihara, Hirasawa (CR59) 2001; 21 Imanishi, Inaba, Seki, Koyama, Nishizawa, Morii, Otani (CR65) 1999; 70 Schwartz, Wang, Zang, Singh, Siegal (CR134) 1997; 6 Beer, Myrthue (CR11) 2004; 3 Weishaar, Simpson (CR162) 1987; 79 Wöbke, Sorg, Steinhilber (CR165) 2014; 5 van de Kerkhof, van Bokhoven, Zultak, Czarnetzki (CR155) 1989; 120 Bernardi, Johnson, Modzelewski, Trump (CR14) 2002; 143 Zhang, Zhang, Studzinski (CR171) 2006; 5 Bikle, Chang, Crumrine, Elalieh, Man, Choi, Dardenne, Xie, Arnaud, Feingold, Elias (CR17) 2004; 122 Colston, Colston, Feldman (CR34) 1981; 108 Echchgadda, Song, Roy, Chatterjee (CR45) 2004; 65 Lemire (CR80) 2000; 59 Rondini, Fang, Runge-Morris, Kocarek (CR128) 2014; 42 Kubodera, Tsuji, Uchiyama, Endo (CR75) 2003; 88 Barker, Ashton, Marks, Harris, Berth-Jones (CR9) 1999; 141 Khan, Chow, van Loenen-Weemaes, Porte, Pang, Groothuis (CR70) 2009; 37 Milde, Hauser, Simon, Mall, Ernst, Haussler, Frosch, Rauterberg (CR100) 1991; 97 Bricker (CR19) 1972; 286 Pèrez, Chen, Turner, Raab, Bhawan, Poche, Holick (CR119) 1996; 134 Nemerovski, Dorsch, Simpson, Bone, Aaronson, Bleske (CR109) 2009; 29 Guzey, Kitada, Reed (CR58) 2002; 1 Maeng, Chapy, Zaman, Pang (CR88) 2012; 46 Fujita, Orimo, Inoue, Kaneda, Sakurai, Morita, Yamamoto, Sugioka, Inoue, Takaoka, Yamamoto, Hoshino, Kawaguchi (CR52) 2007; 25 Thompson, Jurutka, Whitfield, Myskowski, Eichhorst, Dominguez, Haussler, Haussler (CR148) 2002; 299 Abou-Raya, Abou-Raya, Helmii (CR1) 2013; 40 Ananthakrishnan, Khalili, Higuchi, Bao, Korzenik, Giovannucci, Richter, Fuchs, Chan (CR8) 2012; 142 Chow, Durk, Cummins, Pang (CR29) 2011; 337 van de Kerkhof, Berth-Jones, Griffiths, Harrison, Hönigsmann, Marks, Roelandts, Schöpf, Trompke (CR156) 2002; 146 Leyssens, Verlinden, Verstuyf (CR82) 2014; 5 Brown, Ritter, Finch, Morrissey, Martin, Murayama, Nishii, Slatopolsky (CR20) 1989; 84 Park, Lee, Park, Hwang, Shim, Cho, Chung, Bae (CR115) 2012; 27 Francis, Boyle, Moniz, Sutcliffe, Davis, Beastall, Cowan, Downes (CR50) 1996; 6 Chiang, Yeh, Hsu, Yeh, Jan, Wu, Chen, Jwo, Takano, Kittaka, Juang, Chen (CR26) 2013; 15 Xiang, Kong, Chen, Cao, Qiao, Zheng, Liu, Li, Gardner, Li (CR166) 2005; 288 Durakovic, Malabanan, Holick (CR43) 2001; 144 Akizawa, Suzuki, Akiba, Nishizawa, Ohashi, Ogata, Slatopolsky, Kurokawa (CR5) 2002; 17 Schleithoff, Zittermann, Tenderich, Berthold, Stehle, Koerfer (CR131) 2006; 83 Guo, Meng, Liu, Wang, Mao, Sun, Peng, Kaku, Liu (CR57) 2012; 27 McGuire, Trump, Johnson (CR97) 2001; 276 Quach, Noh, Hoi, Bruinsma, Groothuis, Li, Chow, Pang (CR124) 2018; 39 Albert, Kumar, Strugnell, Darjatmoko, Lokken, Lindstrom, Patel (CR7) 2004; 122 Li, Peng, Jiang, Sun, Zhang, Lian, Litonjua, Gao, Gao (CR84) 2011; 81 Lee, So, DeCastro, Smolarek, Paul, Maehr, Uskokovic, Suh (CR78) 2010; 121 Muto, Kizaki, Yamato, Kawai, Kamata-Matsushita, Ueno, Ohguchi, Nishihara, Koeffler, Ikeda (CR104) 1999; 93 Sunyecz (CR146) 2008; 4 Naveilhan, Berger, Haddad, Barbot, Benabid, Brachet, Wion (CR108) 1994; 37 Schwartz, Eads, Naczki, Northrup, Chen, Koumenis (CR135) 2008; 7 Pierrot-Deseilligny, Rivaud-Péchoux, Clerson, de Paz, Souberbielle (CR120) 2012; 5 Xu, Iwanaga, Zhou, Cheesman, Farin, Thummel (CR167) 2006; 28 Simpson, Hershey, Nibbelink (CR140) 2007; 103 Soleymani, Hung, Soung (CR144) 2015; 54 Bikle (CR16) 2014; 21 DeLuca (CR39) 2008; 66 Makishima, Lu, Xie, Whitfield, Domoto, Evans, Haussler, Mangelsdorf (CR90) 2002; 17 Ma, Yu, Trump, Johnson (CR85) 2010; 116 Pendás-Franco, García, Peña, Valle, Pálmer, Heinäniemi, Carlberg, Jiménez, Bonilla, Muñoz, González-Sancho (CR117) 2008; 27 Torres, García, Gómez, González, Barrios, Concepción, Hernández, García, Checa, Lorenzo, Salido (CR150) 2004; 65 Fan, Liu, Du, Morrison, Shipman, Pang (CR48) 2009; 330 Chow, Durk, Maeng, Pang (CR27) 2009; 30 Hargrove, Francis, Francis (CR60) 2014; 2 Seubwai, Wongkham, Puapairoj, Okada, Wongkham (CR136) 2010; 116 Welsh, Wietzke, Zinser, Byrne, Smith, Narvaez (CR164) 2003; 133 van Etten, Mathieu (CR153) 2005; 97 Yasuda, Akiba, Nihei (CR168) 2003; 41 Colston, Chander, Mackay, Coombes (CR35) 1992; 44 Marchwicka, Cebrat, Sampath, Snieżewski, Marcinkowska (CR92) 2014; 4 Barrett, Fang, Kocarek, Runge-Morris (CR10) 2016; 44 Chen, Chen, Liu, Glaeser, Dawson, Hofmann, Kim, Shneider, Pang (CR24) 2006; 69 Hirata, Endo, Katsumata, Ichikawa, Kubodera, Fukagawa (CR62) 2002; 17 Tamura, Ueki, Mashimo, Tsukada, Naitoh, Abe, Kawai, Tsuchida, Wakamatsu, Nojima (CR147) 2005; 9 Katayama, Ohkawara, Ohkido, Harada, Tamaki, Nakagawa, Hori, Nishiyama (CR67) 2002; 12 Ma, Yu, Hidalgo, Luo, Delansorne, Johnson, Trump (CR86) 2013; 12 Richy, Ethgen, Bruyere, Reginster (CR127) 2004; 15 Kragballe, Gjertsen, De Hoop, Karlsmark, van de Kerkhof, Larkö, Nieboer, Roed-Petersen, Strand, Tikjøb (CR74) 1991; 337 Lehmann, Querings, Reichrath (CR79) 2004; 4 Martinelli, Dalla Costa, Colombo, Dalla Libera, Rubinacci, Filippi, Furlan, Comi (CR95) 2014; 20 Zhang, Shih, Zhang (CR172) 2013; 3 Campbell, Koeffler (CR22) 1997; 89 Pálmer, Sánchez-Carbayo, Ordóñez-Morán, Larriba, Cordón-Cardó, Muñoz (CR113) 2003; 63 Kim, Kim, Noh, Quach, Yoon, Chow, Kim, Jin, Cho, Chung, Pang, Maeng (CR71) 2014; 103 Brown, Finch, Lopez-Hilker, Dusso, Ritter, Pernalete, Slatopolsky (CR21) 1990; 29 Sung, Feldman (CR145) 2000; 164 Colston, James, Ofori-Kuragu, Binderup, Grant (CR36) 1997; 76 Daniel, Sartory, Zahn, Radeke, Stein (CR38) 2008; 324 Kawa, Yoshizawa, Tokoo, Imai, Oguchi, Kiyosawa, Homma, Nikaido, Furihata (CR68) 1996; 110 So, Lee, Smolarek, Paul, Wang, Maehr, Uskokovic, Zheng, Conney, Cai, Liu, Suh (CR143) 2011; 79 Bell, Demay, Burnett-Bowie (CR12) 2010; 111 Cross, Huber, Peterlik (CR37) 1991; 179 Narvaez, Matthews, LaPorta, Simmons, Beaudin, Welsh (CR106) 2014; 5 Maeng, Durk, Chow, Ghoneim, Pang (CR87) 2011; 32 Pepper, Thomas, Hoy, Milligan, Bentley, Fegan (CR118) 2003; 101 Walters, Ilenchuk, Claycomb (CR157) 1987; 262 Di Filippo, Scaparrotta, Rapino, Cingolani, Attanasi, Petrosino, Chuang, Di Pillo, Chiarelli (CR41) 2015; 166 Akizawa, Ohashi, Akiba, Suzuki, Nishizawa, Ogata, Slatopolsky, Kurokawa (CR6) 2004; 8 Jiang, Li, Fornace, Nicosia, Bai (CR66) 2003; 278 Schwartz (CR133) 2009; 85 El-Agroudy, El-Husseini, El-Sayed, Ghoneim (CR46) 2003; 14 Schmiedlin-Ren, Thummel, Fisher, Paine, Lown, Watkins (CR132) 1997; 51 Peleg, Uskokovic, Ahene, Vickery, Avnur (CR116) 2002; 143 Ghous, Akhter, Pourgholami, Morris (CR54) 2008; 28 Reichrath (CR126) 2007; 16 Nibbelink, Tishkoff, Hershey, Rahman, Simpson (CR110) 2007; 103 Rahman, Hershey, Ahmed, Nibbelink, Simpson (CR125) 2007; 103 Levin, Wadhera, Leach, Woodhead, Lemberg, Mendoza-Cruz, Day (CR81) 2011; 56 Bollag (CR18) 2007; 127 Morán-Auth, Penna-Martinez, Shoghi, Ramos-Lopez, Badenhoop (CR103) 2013; 136 Duranton, Rodriguez-Ortiz, Duny, Rodriguez, Daurès, Argilés (CR44) 2013; 37 Kragballe, Beck, Søgaard (CR73) 1988; 119 Åivo, Hänninen, Ilonen, Soilu-Hänninen (CR4) 2015; 280 Martin, Gonzales, Gellens, Hamm, Abboud, Lindberg (CR93) 1998; 9 Prietl, Treiber, Pieber, Amrein (CR123) 2013; 5 Holick (CR63) 2004; 79 Adami, Giannini, Bianchi, Sinigaglia, Di Munno, Fiore, Minisola, Rossini (CR2) 2009; 20 Sakai, Demay (CR130) 20 RM Francis (429_CR50) 1996; 6 P Li (429_CR83) 2004; 279 D Felsenberg (429_CR49) 2011; 11 O Aguilera (429_CR3) 2007; 28 RU Simpson (429_CR140) 2007; 103 AA Khan (429_CR70) 2009; 37 K Yudoh (429_CR170) 1999; 133 Y Morán-Auth (429_CR103) 2013; 136 Q Miao (429_CR99) 2013; 48 KJ Martin (429_CR93) 1998; 9 DM Albert (429_CR7) 2004; 122 KW Colston (429_CR36) 1997; 76 HZ Ke (429_CR69) 2005; 20 CW Nemerovski (429_CR109) 2009; 29 KA Nibbelink (429_CR110) 2007; 103 X Wang (429_CR160) 2016; 178 TM Beer (429_CR11) 2004; 3 PC van de Kerkhof (429_CR156) 2002; 146 S Adami (429_CR2) 2009; 20 J Cheng (429_CR25) 2014; 55 T Fujita (429_CR52) 2007; 25 F Duranton (429_CR44) 2013; 37 L Drocourt (429_CR42) 2002; 277 DJ Mantell (429_CR91) 2000; 87 M Guzey (429_CR58) 2002; 1 RJ Grostern (429_CR56) 2002; 120 R Okamoto (429_CR112) 2012; 130 B Prietl (429_CR123) 2013; 5 SH Zhuang (429_CR173) 1998; 139 TD Bell (429_CR12) 2010; 111 S Kawa (429_CR68) 1996; 110 JJ Eloranta (429_CR47) 2012; 82 HJ Maeng (429_CR88) 2012; 46 AJ Brown (429_CR20) 1989; 84 EC Chow (429_CR31) 2013; 34 E van Etten (429_CR153) 2005; 97 YC Kim (429_CR71) 2014; 103 M Hirata (429_CR62) 2002; 17 GG Schwartz (429_CR134) 1997; 6 MF Holick (429_CR64) 1996; 1 P Di Filippo (429_CR41) 2015; 166 KJ Martin (429_CR94) 1998; 32 EC Chow (429_CR28) 2010; 31 V Bhatia (429_CR15) 2009; 8 AJ Brown (429_CR21) 1990; 29 K Hara (429_CR59) 2001; 21 KG Barrett (429_CR10) 2016; 44 S Majewski (429_CR89) 1996; 1 P Milde (429_CR100) 1991; 97 QM Wang (429_CR158) 1996; 56 Y Ma (429_CR85) 2010; 116 J Lemire (429_CR80) 2000; 59 MF Holick (429_CR63) 2004; 79 HJ Maeng (429_CR87) 2011; 32 TF McGuire (429_CR97) 2001; 276 N Kubodera (429_CR75) 2003; 88 HP Quach (429_CR124) 2018; 39 C Zierold (429_CR174) 2006; 69 SG Rostand (429_CR129) 1999; 56 DD Bikle (429_CR17) 2004; 122 K Nakagawa (429_CR105) 2005; 26 NK Shevde (429_CR139) 2002; 99 I Echchgadda (429_CR45) 2004; 65 TK Wöbke (429_CR165) 2014; 5 AN Ananthakrishnan (429_CR8) 2012; 142 HG Pálmer (429_CR113) 2003; 63 C Daniel (429_CR38) 2008; 324 V Martinelli (429_CR95) 2014; 20 S Goto (429_CR55) 2008; 1 A Rahman (429_CR125) 2007; 103 J Welsh (429_CR164) 2003; 133 K Kragballe (429_CR73) 1988; 119 S Peleg (429_CR116) 2002; 143 C Pepper (429_CR118) 2003; 101 HS Cross (429_CR37) 1991; 179 HJ Lee (429_CR78) 2010; 121 N Pendás-Franco (429_CR117) 2008; 27 CJ Narvaez (429_CR106) 2014; 5 W Seubwai (429_CR136) 2010; 116 EC Chow (429_CR27) 2009; 30 MC Monier-Faugere (429_CR102) 1999; 55 Y Xu (429_CR167) 2006; 28 V Sung (429_CR145) 2000; 164 MJ Campbell (429_CR22) 1997; 89 F Jiang (429_CR66) 2003; 278 EA Rondini (429_CR128) 2014; 42 PC van de Kerkhof (429_CR155) 1989; 120 KC Chiang (429_CR26) 2013; 15 Y Miyachi (429_CR101) 2002; 12 RE Weishaar (429_CR162) 1987; 79 EC Chow (429_CR29) 2011; 337 A Abou-Raya (429_CR1) 2013; 40 P Schmiedlin-Ren (429_CR132) 1997; 51 KW Colston (429_CR35) 1992; 44 M Yasuda (429_CR168) 2003; 41 GG Schwartz (429_CR135) 2008; 7 X Guo (429_CR57) 2012; 27 SA Shedeed (429_CR138) 2012; 33 A Torres (429_CR150) 2004; 65 M Hayashi (429_CR61) 2004; 19 X Chen (429_CR24) 2006; 69 J Reichrath (429_CR126) 2007; 16 RH Getzenberg (429_CR53) 1997; 50 PD Thompson (429_CR148) 2002; 299 Y Ma (429_CR86) 2013; 12 Y Zhang (429_CR171) 2006; 5 W Xiang (429_CR166) 2005; 288 BP Kota (429_CR72) 2012; 26 C Pierrot-Deseilligny (429_CR120) 2012; 5 Y Shapira (429_CR137) 2010; 6 IS Yoon (429_CR169) 2015; 38 H Zhang (429_CR172) 2013; 3 Y Nishizawa (429_CR111) 1991; 90 NS Bricker (429_CR19) 1972; 286 A Muto (429_CR104) 1999; 93 A Bener (429_CR13) 2012; 157 EC Chow (429_CR30) 2011; 100 DD Bikle (429_CR16) 2014; 21 E Slatopolsky (429_CR141) 1995; 26 Y Imanishi (429_CR65) 1999; 70 F Li (429_CR84) 2011; 81 E Slatopolsky (429_CR142) 2003; 63 K Colston (429_CR34) 1981; 108 B Lehmann (429_CR79) 2004; 4 J Åivo (429_CR4) 2015; 280 S Pilz (429_CR122) 2008; 93 C Carlberg (429_CR23) 1995; 231 HF DeLuca (429_CR39) 2008; 66 TC McCarthy (429_CR96) 2005; 280 JN Barker (429_CR9) 1999; 141 MB Meyer (429_CR98) 2012; 26 MR Park (429_CR115) 2012; 27 F Richy (429_CR127) 2004; 15 T Soleymani (429_CR144) 2015; 54 A Pèrez (429_CR119) 1996; 134 WB Bollag (429_CR18) 2007; 127 I Chung (429_CR32) 2009; 69 MR Walters (429_CR157) 1987; 262 JY So (429_CR143) 2011; 79 C Durakovic (429_CR43) 2001; 144 T Kumagai (429_CR76) 2003; 95 K Kragballe (429_CR74) 1991; 337 Z Ghous (429_CR54) 2008; 28 TJ Wang (429_CR159) 2008; 117 Y Sakai (429_CR130) 2000; 141 T Akizawa (429_CR6) 2004; 8 JA Sunyecz (429_CR146) 2008; 4 M Makishima (429_CR90) 2002; 17 E Papadimitropoulos (429_CR114) 2002; 23 T Akizawa (429_CR5) 2002; 17 J Fan (429_CR48) 2009; 330 I Katayama (429_CR67) 2002; 12 T Naveh-Many (429_CR107) 1993; 133 RE Weishaar (429_CR163) 1990; 258 S Pilz (429_CR121) 2008; 39 AE El-Agroudy (429_CR46) 2003; 14 P Naveilhan (429_CR108) 1994; 37 PR van Ginkel (429_CR154) 2007; 85 C Leyssens (429_CR82) 2014; 5 RE Weishaar (429_CR161) 1987; 253 A Marchwicka (429_CR92) 2014; 4 T Fujioka (429_CR51) 1998; 160 L Hargrove (429_CR60) 2014; 2 AD Levin (429_CR81) 2011; 56 S Tamura (429_CR147) 2005; 9 KE Thummel (429_CR149) 2001; 60 DL Trump (429_CR152) 2010; 16 RJ Bernardi (429_CR14) 2002; 143 JW Coburn (429_CR33) 2004; 43 HF DeLuca (429_CR40) 2011; 26 SS Schleithoff (429_CR131) 2006; 83 JB Schwartz (429_CR133) 2009; 85 L Trémezaygues (429_CR151) 2011; 3 MS LeBoff (429_CR77) 1999; 251 |
References_xml | – volume: 279 start-page: 25260 year: 2004 end-page: 25267 ident: CR83 article-title: p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase publication-title: J Biol Chem – volume: 27 start-page: 1037 year: 2012 end-page: 1043 ident: CR115 article-title: Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model publication-title: J Korean Med Sci – volume: 66 start-page: S73 year: 2008 end-page: S87 ident: CR39 article-title: Evolution of our understanding of vitamin D publication-title: Nutr Rev – volume: 141 start-page: 2043 year: 2000 end-page: 2049 ident: CR130 article-title: Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice publication-title: Endocrinology – volume: 28 start-page: 1877 year: 2007 end-page: 1884 ident: CR3 article-title: The Wnt antagonist DICKKOPF-1 gene is induced by 1α,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells publication-title: Carcinogenesis – volume: 11 start-page: 34 year: 2011 end-page: 45 ident: CR49 article-title: Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass publication-title: J Musculoskelet Neuronal Interact – volume: 142 start-page: 482 year: 2012 end-page: 489 ident: CR8 article-title: Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease publication-title: Gastroenterology – volume: 120 start-page: 607 year: 2002 end-page: 612 ident: CR56 article-title: Toxicity and dose-response studies of 1α-hydroxyvitamin D2 in a retinoblastoma xenograft model publication-title: Arch Ophthalmol – volume: 99 start-page: 13487 year: 2002 end-page: 13491 ident: CR139 article-title: A potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation publication-title: Proc Natl Acad Sci USA – volume: 4 start-page: 827 year: 2008 end-page: 836 ident: CR146 article-title: The use of calcium and vitamin D in the management of osteoporosis publication-title: Ther Clin Risk Manag – volume: 9 start-page: 238 year: 2005 end-page: 243 ident: CR147 article-title: Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients publication-title: Clin Exp Nephrol – volume: 280 start-page: 12 year: 2015 end-page: 15 ident: CR4 article-title: Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta publication-title: J Neuroimmunol – volume: 31 start-page: 91 year: 2010 end-page: 108 ident: CR28 article-title: Effects of 1α,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney . publication-title: Biopharm Drug Dispos – volume: 20 start-page: 147 year: 2014 end-page: 155 ident: CR95 article-title: Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes publication-title: Mult Scler – volume: 20 start-page: 239 year: 2009 end-page: 244 ident: CR2 article-title: Vitamin D status and response to treatment in post-menopausal osteoporosis publication-title: Osteoporos Int – volume: 231 start-page: 517 issue: 3 year: 1995 end-page: 527 ident: CR23 article-title: Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling publication-title: Eur J Biochem – volume: 262 start-page: 2536 year: 1987 end-page: 2541 ident: CR157 article-title: 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells publication-title: J Biol Chem – volume: 97 start-page: 93 year: 2005 end-page: 101 ident: CR153 article-title: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts publication-title: J Steroid Biochem Mol Biol – volume: 8 start-page: 1787 year: 2009 end-page: 1798 ident: CR15 article-title: EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells publication-title: Mol Cancer Ther – volume: 16 start-page: 618 year: 2007 end-page: 625 ident: CR126 article-title: Vitamin D and the skin: an ancient friend, revisited publication-title: Exp Dermatol – volume: 48 start-page: 351 year: 2013 end-page: 359 ident: CR99 article-title: Inhibitory effect of 1α,25-dihydroxyvitamin D on excretion of JBP485 via organic anion transporters in rats publication-title: Eur J Pharm Sci – volume: 6 start-page: 468 year: 2010 end-page: 476 ident: CR137 article-title: Geoepidemiology of autoimmune rheumatic diseases publication-title: Nat Rev Rheumatol – volume: 70 start-page: 243 year: 1999 end-page: 248 ident: CR65 article-title: Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells publication-title: J Steroid Biochem Mol Biol – volume: 26 start-page: 538 year: 2011 end-page: 545 ident: CR40 article-title: The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial publication-title: J Bone Miner Res – volume: 120 start-page: 661 year: 1989 end-page: 664 ident: CR155 article-title: A double-blind study of topical 1 α,25-dihydroxyvitamin D3 in psoriasis publication-title: Br J Dermatol – volume: 37 start-page: 115 issue: 2 year: 2009 end-page: 125 ident: CR70 article-title: Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver publication-title: Eur J Pharm Sci – volume: 12 start-page: 553 year: 2002 end-page: 557 ident: CR67 article-title: High-concentration (20mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids publication-title: Eur J Dermatol – volume: 3 start-page: 237 year: 2013 end-page: 240 ident: CR172 article-title: Mechanisms underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells publication-title: Eur J Microbiol Immunol (Bp) – volume: 110 start-page: 1605 year: 1996 end-page: 1613 ident: CR68 article-title: Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines publication-title: Gastroenterology – volume: 17 start-page: 41 issue: suppl 10 year: 2002 end-page: 45 ident: CR62 article-title: A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone and calcemic action publication-title: Nephrol Dial Transplant – volume: 134 start-page: 238 year: 1996 end-page: 246 ident: CR119 article-title: Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis publication-title: Br J Dermatol – volume: 26 start-page: 37 year: 2012 end-page: 51 ident: CR98 article-title: VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression publication-title: Mol Endocrinol – volume: 32 start-page: S61 year: 1998 end-page: S66 ident: CR94 article-title: Therapy of secondary hyperparathyroidism with 19-nor-1a,25-dihydroxyvitamin D2 publication-title: Am J Kidney Dis – volume: 63 start-page: 2020 year: 2003 end-page: 2027 ident: CR142 article-title: Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia publication-title: Kidney Int – volume: 8 start-page: 480 year: 2004 end-page: 491 ident: CR6 article-title: Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism publication-title: Ther Apher Dial – volume: 251 start-page: 1505 year: 1999 end-page: 1511 ident: CR77 article-title: Occult vitamin D deficiency in postmenopausal US women with acute hip fracture publication-title: JAMA – volume: 166 start-page: 91 year: 2015 end-page: 96 ident: CR41 article-title: Vitamin D supplementation modulates the immune system and improves atopic dermatitis in children publication-title: Int Arch Allergy Immunol – volume: 46 start-page: 149 year: 2012 end-page: 166 ident: CR88 article-title: Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells publication-title: Eur J Pharm Sci – volume: 133 start-page: 2425S year: 2003 end-page: 2433S ident: CR164 article-title: Vitamin D-3 receptor as a target for breast cancer prevention publication-title: J Nutr – volume: 28 start-page: 385 year: 2006 end-page: 392 ident: CR167 article-title: Selective induction of intestinal CYP3A23 by 1α,25-dihydroxyvitamin D3 in rats publication-title: Biochem Pharmacol – volume: 87 start-page: 214 year: 2000 end-page: 220 ident: CR91 article-title: 1 α,25-dihydroxyvitamin D(3) inhibits angiogenesis and publication-title: Circ Res – volume: 5 start-page: 447 year: 2006 end-page: 451 ident: CR171 article-title: AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells publication-title: Cell Cycle – volume: 1 start-page: 1 year: 1996 end-page: 9 ident: CR64 article-title: Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective publication-title: J Investig Dermatol Symp Proc – volume: 117 start-page: 503 year: 2008 end-page: 511 ident: CR159 article-title: Vitamin D deficiency and risk of cardiovascular disease publication-title: Circulation – volume: 178 start-page: 54 year: 2016 end-page: 62 ident: CR160 article-title: 1-A, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10 publication-title: Transl Res – volume: 15 start-page: 1316 year: 2013 end-page: 1325 ident: CR26 article-title: Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells and publication-title: Cell Cycle – volume: 51 start-page: 741 issue: 5 year: 1997 end-page: 754 ident: CR132 article-title: Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3 publication-title: Mol Pharmacol – volume: 44 start-page: 693 year: 1992 end-page: 702 ident: CR35 article-title: Effects of synthetic vitamin D analogues on breast cancer cell proliferation and publication-title: Biochem Pharmacol – volume: 1 start-page: iii2 issue: Suppl 3 year: 2008 end-page: iii8 ident: CR55 article-title: Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention publication-title: NDT Plus – volume: 81 start-page: 469 year: 2011 end-page: 475 ident: CR84 article-title: Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma publication-title: Respiration – volume: 37 start-page: 239 year: 2013 end-page: 248 ident: CR44 article-title: Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis publication-title: Am J Nephrol – volume: 6 start-page: 284 year: 1996 end-page: 290 ident: CR50 article-title: A comparison of the effects of alfacalcidol treatment and vitamin D2 supplementation on calcium absorption in elderly women with vertebral fractures publication-title: Osteoporos Int – volume: 127 start-page: 748 year: 2007 end-page: 750 ident: CR18 article-title: Differentiation of human keratinocytes requires the Vitamin D receptor and its coactivators publication-title: J Invest Dermatol – volume: 4 start-page: 125 year: 2014 ident: CR92 article-title: Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients’ variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs publication-title: Front Oncol – volume: 299 start-page: 730 issue: 5 year: 2002 end-page: 738 ident: CR148 article-title: Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements publication-title: Biochem Biophys Res Commun – volume: 38 start-page: 1732 year: 2015 end-page: 1737 ident: CR169 article-title: Effects of 1α,25-Dihydroxyvitamin D3 on intestinal absorption and disposition of adefovir dipivoxil and its metabolite, adefovir, in Rats publication-title: Biol Pharm Bull – volume: 4 start-page: 11 year: 2004 end-page: 15 ident: CR79 article-title: Vitamin D and skin: new aspects for dermatology publication-title: Exp Dermatol 13 Suppl – volume: 15 start-page: 301 year: 2004 end-page: 310 ident: CR127 article-title: Efficacy of αcalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate publication-title: Osteoporos Int – volume: 1 start-page: 667 year: 2002 end-page: 677 ident: CR58 article-title: Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer publication-title: Mol Cancer Ther – volume: 26 start-page: 429 year: 2005 end-page: 440 ident: CR105 article-title: 1 α,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer publication-title: Carcinogenesis – volume: 130 start-page: 2464 year: 2012 end-page: 2473 ident: CR112 article-title: Inecalcitol, an analog of 1α,25(OH)(2) D(3), induces growth arrest of androgen-dependent prostate cancer cells publication-title: Int J Cancer – volume: 100 start-page: 1594 year: 2011 end-page: 1604 ident: CR30 article-title: Comparative effects of doxercalciferol (1α-hydroxyvitamin D ) versus calcitriol (1α,25-dihydroxyvitamin D ) on the expression of transporters and enzymes in the rat publication-title: J Pharm Sci – volume: 79 start-page: 1706 year: 1987 end-page: 1712 ident: CR162 article-title: Vitamin D3 and cardiovascular function in rats publication-title: J Clin Invest – volume: 29 start-page: S22 issue: Suppl. 29 year: 1990 end-page: S27 ident: CR21 article-title: New active analogues of vitamin D with low calcemic activity publication-title: Kidney Int – volume: 39 start-page: 2611 year: 2008 end-page: 2613 ident: CR121 article-title: Low vitamin d levels predict stroke in patients referred to coronary angiography publication-title: Stroke – volume: 5 start-page: 2502 year: 2013 end-page: 2521 ident: CR123 article-title: Vitamin D and Immune Function publication-title: Nutrients – volume: 44 start-page: 1431 issue: 8 year: 2016 end-page: 1434 ident: CR10 article-title: Transcriptional regulation of cytosolic sulfotransferase 1C2 by vitamin D receptor in LS180 human colorectal adenocarcinoma cells publication-title: Drug Metab Dispos – volume: 160 start-page: 247 year: 1998 end-page: 251 ident: CR51 article-title: Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma publication-title: J Urol – volume: 141 start-page: 274 year: 1999 end-page: 278 ident: CR9 article-title: Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator publication-title: Br J Dermatol – volume: 79 start-page: 362 year: 2004 end-page: 371 ident: CR63 article-title: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis publication-title: Am J Clin Nutr – volume: 79 start-page: 360 year: 2011 end-page: 367 ident: CR143 article-title: A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer publication-title: Mol Pharmacol – volume: 41 start-page: S108 year: 2003 end-page: S111 ident: CR168 article-title: Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients publication-title: Am J Kidney Dis – volume: 32 start-page: 112 year: 2011 end-page: 125 ident: CR87 article-title: 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac publication-title: Biopharm Drug Dispos – volume: 42 start-page: 361 issue: 3 year: 2014 end-page: 368 ident: CR128 article-title: Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells publication-title: Drug Metab Dispos – volume: 76 start-page: 1017 year: 1997 end-page: 1020 ident: CR36 article-title: Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells and publication-title: Br J Cancer – volume: 84 start-page: 728 year: 1989 end-page: 732 ident: CR20 article-title: The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion publication-title: J Clin Invest – volume: 82 start-page: 37 year: 2012 end-page: 46 ident: CR47 article-title: The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor publication-title: Mol Pharmacol – volume: 157 start-page: 168 year: 2012 end-page: 175 ident: CR13 article-title: Vitamin D deficiency as a strong predictor of asthma in children publication-title: Int Arch Allergy Immunol – volume: 27 start-page: 232 year: 2012 end-page: 241 ident: CR57 article-title: Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats publication-title: Drug Metab Pharmacokinet – volume: 122 start-page: 984 year: 2004 end-page: 992 ident: CR17 article-title: 25-Hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis publication-title: J Invest Dermatol – volume: 258 start-page: E134 year: 1990 end-page: E142 ident: CR163 article-title: Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties publication-title: Am J Physiol – volume: 179 start-page: 57 year: 1991 end-page: 62 ident: CR37 article-title: Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium publication-title: Biochem Biophys Res Commun – volume: 143 start-page: 1625 year: 2002 end-page: 1636 ident: CR116 article-title: Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats publication-title: Endocrinology – volume: 116 start-page: 5535 year: 2010 end-page: 5543 ident: CR136 article-title: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma publication-title: Cancer – volume: 56 start-page: 830 year: 2011 end-page: 836 ident: CR81 article-title: Vitamin D deficiency in children with inflammatory bowel disease publication-title: Dig Dis Sci – volume: 103 start-page: 533 year: 2007 end-page: 537 ident: CR110 article-title: 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte publication-title: J Steroid Biochem Mol Biol – volume: 33 start-page: 713 year: 2012 end-page: 719 ident: CR138 article-title: Vitamin D supplementation in infants with chronic congestive heart failure publication-title: Pediatr Cardiol – volume: 144 start-page: 500 year: 2001 end-page: 506 ident: CR43 article-title: Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study publication-title: Br J Dermatol – volume: 337 start-page: 193 year: 1991 end-page: 196 ident: CR74 article-title: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris publication-title: Lancet – volume: 324 start-page: 23 year: 2008 end-page: 33 ident: CR38 article-title: Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile publication-title: Pharmacol Exp Ther – volume: 95 start-page: 896 year: 2003 end-page: 905 ident: CR76 article-title: Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells publication-title: J Natl Cancer Inst – volume: 55 start-page: 821 year: 1999 end-page: 832 ident: CR102 article-title: 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure publication-title: Kidney Int – volume: 12 start-page: 463 year: 2002 end-page: 468 ident: CR101 article-title: Long-term safety and efficacy of high-concentration (20microg/g) tacalcitol ointment in psoriasis vulgaris publication-title: Eur J Dermatol – volume: 59 start-page: 24 issue: Suppl 1 year: 2000 end-page: 27 ident: CR80 article-title: 1,25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties publication-title: Z Rheumatol – volume: 12 start-page: 743 year: 2013 end-page: 752 ident: CR86 article-title: Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system publication-title: Cell Cycle – volume: 1 start-page: 97 year: 1996 end-page: 101 ident: CR89 article-title: Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis publication-title: J Investig Dermatol Symp Proc – volume: 60 start-page: 1399 year: 2001 end-page: 1406 ident: CR149 article-title: Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D3 publication-title: Mol Pharmacol – volume: 89 start-page: 182 year: 1997 end-page: 185 ident: CR22 article-title: Toward therapeutic intervention of cancer by vitamin D compounds publication-title: J Natl Cancer Inst – volume: 276 start-page: 26365 year: 2001 end-page: 26373 ident: CR97 article-title: Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1 publication-title: J Biol Chem – volume: 43 start-page: 877 issue: 5 year: 2004 end-page: 890 ident: CR33 article-title: Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4 publication-title: Am J Kidney Dis – volume: 69 start-page: 1913 year: 2006 end-page: 1923 ident: CR24 article-title: Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1α,25-dihydroxyvitamin D3 via the vitamin D receptor publication-title: Mol Pharmacol – volume: 103 start-page: 3793 year: 2014 end-page: 3805 ident: CR71 article-title: Effects of 1α,25-dihydroxyvitamin D3, the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat publication-title: J Pharm Sci – volume: 56 start-page: 264 year: 1996 end-page: 267 ident: CR158 article-title: Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells publication-title: Cancer Res – volume: 17 start-page: 1313 year: 2002 end-page: 1316 ident: CR90 article-title: Vitamin D receptor as an intestinal bile acid sensor publication-title: Science – volume: 88 start-page: 286 year: 2003 end-page: 289 ident: CR75 article-title: A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients publication-title: J Cell Biochem – volume: 40 start-page: 265 year: 2013 end-page: 272 ident: CR1 article-title: The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial publication-title: J Rheumatol – volume: 26 start-page: 543 year: 2012 end-page: 548 ident: CR72 article-title: Effect of vitamin D3 supplementation on the pharmacokinetics of digoxin—a pilot study publication-title: Fundam Clin Pharmacol – volume: 26 start-page: 852 year: 1995 end-page: 860 ident: CR141 article-title: A new analog of calcitriol, 19-nor-1,25-(OH)2 D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia publication-title: Am J Kidney Dis – volume: 111 start-page: 7 year: 2010 end-page: 13 ident: CR12 article-title: The biology and pathology of vitamin D control in bone publication-title: J Cell Biochem – volume: 136 start-page: 83 year: 2013 end-page: 85 ident: CR103 article-title: Vitamin D status and gene transcription in immune cells publication-title: J Steroid Biochem Mol Biol – volume: 5 start-page: 122 year: 2014 ident: CR82 article-title: The future of vitamin D analogs publication-title: Front Physiol – volume: 277 start-page: 25125 issue: 28 year: 2002 end-page: 25132 ident: CR42 article-title: Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes publication-title: J Biol Chem – volume: 37 start-page: 271 year: 1994 end-page: 277 ident: CR108 article-title: Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? publication-title: J Neurosci Res – volume: 103 start-page: 521 year: 2007 end-page: 524 ident: CR140 article-title: Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse publication-title: J Steroid Biochem Mol Biol – volume: 3 start-page: 180 year: 2011 end-page: 186 ident: CR151 article-title: Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going? publication-title: Dermatoendocrinol – volume: 63 start-page: 7799 year: 2003 end-page: 7806 ident: CR113 article-title: Genetic signatures of differentiation induced by 1α,25-dihydroxyvitamin D3 in human colon cancer cells publication-title: Cancer Res – volume: 253 start-page: E675 year: 1987 end-page: E683 ident: CR161 article-title: Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects publication-title: Am J Physiol – volume: 21 start-page: 321 year: 2001 end-page: 324 ident: CR59 article-title: Oral administration of 1α hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model publication-title: Anticancer Res – volume: 5 start-page: 187 year: 2012 end-page: 198 ident: CR120 article-title: Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation publication-title: Ther Adv Neurol Disord – volume: 30 start-page: 457 year: 2009 end-page: 475 ident: CR27 article-title: 1α,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver publication-title: Biopharm Drug Dispos – volume: 3 start-page: 373 year: 2004 end-page: 381 ident: CR11 article-title: Calcitriol in cancer treatment: from the lab to the clinic publication-title: Mol Cancer Ther – volume: 288 start-page: E125 year: 2005 end-page: E132 ident: CR166 article-title: Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems publication-title: Am J Physiol Endocrinol Metab – volume: 83 start-page: 754 year: 2006 end-page: 759 ident: CR131 article-title: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial publication-title: Am J Clin Nutr – volume: 93 start-page: 2225 year: 1999 end-page: 2233 ident: CR104 article-title: 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1) publication-title: Blood – volume: 69 start-page: 1740 year: 2006 end-page: 1747 ident: CR174 article-title: 19nor-1,25-dihydroxyvitamin D2 specifically induces CYP3A9 in rat intestine more strongly than 1,25-dihydroxyvitamin D3 and publication-title: Mol Pharmacol – volume: 56 start-page: 383 year: 1999 end-page: 392 ident: CR129 article-title: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure publication-title: Kidney Int – volume: 19 start-page: 2067 year: 2004 end-page: 2073 ident: CR61 article-title: Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial publication-title: Nephrol Dial Transplant – volume: 85 start-page: 255 year: 2007 end-page: 262 ident: CR154 article-title: 1 α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma publication-title: J Neurooncol – volume: 2 start-page: 9 year: 2014 ident: CR60 article-title: Vitamin D and GI cancers: shedding some light on dark diseases publication-title: Ann Transl Med – volume: 133 start-page: 2724 year: 1993 end-page: 2728 ident: CR107 article-title: Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression publication-title: Endocrinology – volume: 17 start-page: 28 issue: Suppl. 10 year: 2002 end-page: 36 ident: CR5 article-title: Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study publication-title: Nephrol Dial Transplant – volume: 103 start-page: 416 year: 2007 end-page: 419 ident: CR125 article-title: Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice publication-title: J Steroid Biochem Mol Biol – volume: 116 start-page: 3294 year: 2010 end-page: 3303 ident: CR85 article-title: 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models publication-title: Cancer – volume: 139 start-page: 1197 year: 1998 end-page: 1207 ident: CR173 article-title: Antiproliferative effect of 1α,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation publication-title: Endocrinology – volume: 286 start-page: 1093 year: 1972 end-page: 1099 ident: CR19 article-title: On the pathogenesis of the uremic state. An exposition of the ‘trade-off hypothesis’ publication-title: N Engl J Med – volume: 28 start-page: 3757 year: 2008 end-page: 3761 ident: CR54 article-title: Inhibition of hepatocellular cancer by EB1089: and study publication-title: Anticancer Res – volume: 5 start-page: 213 year: 2014 ident: CR106 article-title: The impact of vitamin D in breast cancer: genomics, pathways, metabolism publication-title: Front Physiol – volume: 39 start-page: 99 year: 2018 end-page: 115 ident: CR124 article-title: Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in mice publication-title: Biopharm Drug Dispos – volume: 6 start-page: 727 year: 1997 end-page: 732 ident: CR134 article-title: 1α,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells publication-title: Cancer Epidemiol Biomarkers Prev – volume: 65 start-page: 720 issue: 3 year: 2004 end-page: 729 ident: CR45 article-title: Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor publication-title: Mol Pharmacol – volume: 280 start-page: 23232 issue: 24 year: 2005 end-page: 23242 ident: CR96 article-title: Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids publication-title: J Biol Chem – volume: 97 start-page: 230 year: 1991 end-page: 239 ident: CR100 article-title: Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin publication-title: J Invest Dermatol – volume: 25 start-page: 130 year: 2007 end-page: 137 ident: CR52 article-title: Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol publication-title: J Bone Miner Metab – volume: 133 start-page: 120 year: 1999 end-page: 128 ident: CR170 article-title: 1α,25-dihydroxyvitamin D3 inhibits invasiveness through the extracellular matrix and pulmonary metastasis of B16 mouse melanoma publication-title: J Lab Clin Med – volume: 108 start-page: 1083 year: 1981 end-page: 1086 ident: CR34 article-title: 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture publication-title: Endocrinology – volume: 278 start-page: 48030 year: 2003 end-page: 48040 ident: CR66 article-title: G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer publication-title: J Biol Chem – volume: 93 start-page: 3927 year: 2008 end-page: 3935 ident: CR122 article-title: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography publication-title: J Clin Endocrinol Metab – volume: 23 start-page: 560 year: 2002 end-page: 569 ident: CR114 article-title: Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women publication-title: Endocr Rev – volume: 21 start-page: 319 year: 2014 end-page: 329 ident: CR16 article-title: Vitamin D metabolism, mechanism of action, and clinical applications publication-title: Chem Biol – volume: 69 start-page: 967 year: 2009 end-page: 975 ident: CR32 article-title: Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis publication-title: Cancer Res – volume: 90 start-page: 196 year: 1991 end-page: 203 ident: CR111 article-title: Clinical trial of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 in uremic patients on hemodialysis: preliminary report publication-title: Contrib Nephrol – volume: 14 start-page: 2975 year: 2003 end-page: 2979 ident: CR46 article-title: Preventing bone loss in renal transplant recipients with vitamin D publication-title: J Am Soc Nephrol – volume: 50 start-page: 999 year: 1997 end-page: 1006 ident: CR53 article-title: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system publication-title: Urology – volume: 101 start-page: 2454 year: 2003 end-page: 2460 ident: CR118 article-title: The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells publication-title: Blood – volume: 65 start-page: 705 year: 2004 end-page: 712 ident: CR150 article-title: Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation publication-title: Kidney Int – volume: 122 start-page: 1357 year: 2004 end-page: 1362 ident: CR7 article-title: Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models publication-title: Arch Ophthalmol – volume: 20 start-page: 1742 year: 2005 end-page: 1755 ident: CR69 article-title: A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia publication-title: J Bone Miner Res – volume: 119 start-page: 223 year: 1988 end-page: 230 ident: CR73 article-title: Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study publication-title: Br J Dermatol – volume: 54 start-page: 383 year: 2015 end-page: 392 ident: CR144 article-title: The role of vitamin D in psoriasis: a review publication-title: Int J Dermatol – volume: 16 start-page: 1 year: 2010 end-page: 9 ident: CR152 article-title: Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy publication-title: Cancer J – volume: 9 start-page: 1427 year: 1998 end-page: 1432 ident: CR93 article-title: 19-Nor-1a,25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis publication-title: J Am Soc Nephrol – volume: 330 start-page: 389 year: 2009 end-page: 402 ident: CR48 article-title: Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1α,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer publication-title: J Pharmacol Exp Ther – volume: 5 start-page: 244 year: 2014 ident: CR165 article-title: Vitamin D in inflammatory diseases publication-title: Front Physiol – volume: 55 start-page: 455 issue: 3 year: 2014 end-page: 465 ident: CR25 article-title: Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice publication-title: J Lipid Res – volume: 164 start-page: 133 year: 2000 end-page: 143 ident: CR145 article-title: 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration publication-title: Mol Cell Endocrinol – volume: 85 start-page: 198 issue: 2 year: 2009 end-page: 203 ident: CR133 article-title: Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence publication-title: Clin Pharmacol Ther – volume: 27 start-page: 4467 year: 2008 end-page: 4477 ident: CR117 article-title: DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1α,25-dihydroxyvitamin D3 publication-title: Oncogene – volume: 121 start-page: 408 year: 2010 end-page: 412 ident: CR78 article-title: Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling publication-title: J Steroid Biochem Mol Biol – volume: 34 start-page: 402 year: 2013 end-page: 416 ident: CR31 article-title: Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice publication-title: Biopharm Drug Dispos – volume: 7 start-page: 430 year: 2008 end-page: 436 ident: CR135 article-title: 19-nor-1 α,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells and publication-title: Cancer Biol Ther – volume: 146 start-page: 414 year: 2002 end-page: 422 ident: CR156 article-title: Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis publication-title: Br J Dermatol – volume: 337 start-page: 846 year: 2011 end-page: 859 ident: CR29 article-title: 1A,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice publication-title: J Pharmacol Exp Ther – volume: 29 start-page: 691 year: 2009 end-page: 708 ident: CR109 article-title: Vitamin D and cardiovascular disease publication-title: Pharmacotherapy – volume: 143 start-page: 2508 year: 2002 end-page: 2514 ident: CR14 article-title: Antiproliferative effects of 1α,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells publication-title: Endocrinology – volume: 286 start-page: 1093 year: 1972 ident: 429_CR19 publication-title: N Engl J Med doi: 10.1056/NEJM197205182862009 – volume: 28 start-page: 3757 year: 2008 ident: 429_CR54 publication-title: Anticancer Res – volume: 251 start-page: 1505 year: 1999 ident: 429_CR77 publication-title: JAMA doi: 10.1001/jama.281.16.1505 – volume: 81 start-page: 469 year: 2011 ident: 429_CR84 publication-title: Respiration doi: 10.1159/000322008 – volume: 23 start-page: 560 year: 2002 ident: 429_CR114 publication-title: Endocr Rev doi: 10.1210/er.2001-8002 – volume: 120 start-page: 607 year: 2002 ident: 429_CR56 publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.5.607 – volume: 143 start-page: 2508 year: 2002 ident: 429_CR14 publication-title: Endocrinology doi: 10.1210/endo.143.7.8887 – volume: 100 start-page: 1594 year: 2011 ident: 429_CR30 publication-title: J Pharm Sci doi: 10.1002/jps.22366 – volume: 299 start-page: 730 issue: 5 year: 2002 ident: 429_CR148 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)02742-0 – volume: 27 start-page: 232 year: 2012 ident: 429_CR57 publication-title: Drug Metab Pharmacokinet doi: 10.2133/dmpk.DMPK-11-RG-089 – volume: 93 start-page: 3927 year: 2008 ident: 429_CR122 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0784 – volume: 4 start-page: 125 year: 2014 ident: 429_CR92 publication-title: Front Oncol doi: 10.3389/fonc.2014.00125 – volume: 108 start-page: 1083 year: 1981 ident: 429_CR34 publication-title: Endocrinology doi: 10.1210/endo-108-3-1083 – volume: 63 start-page: 7799 year: 2003 ident: 429_CR113 publication-title: Cancer Res – volume: 34 start-page: 402 year: 2013 ident: 429_CR31 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.1856 – volume: 84 start-page: 728 year: 1989 ident: 429_CR20 publication-title: J Clin Invest doi: 10.1172/JCI114229 – volume: 11 start-page: 34 year: 2011 ident: 429_CR49 publication-title: J Musculoskelet Neuronal Interact – volume: 99 start-page: 13487 year: 2002 ident: 429_CR139 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.202471299 – volume: 26 start-page: 538 year: 2011 ident: 429_CR40 publication-title: J Bone Miner Res doi: 10.1002/jbmr.256 – volume: 19 start-page: 2067 year: 2004 ident: 429_CR61 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfh329 – volume: 12 start-page: 743 year: 2013 ident: 429_CR86 publication-title: Cell Cycle doi: 10.4161/cc.23846 – volume: 120 start-page: 661 year: 1989 ident: 429_CR155 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.1989.tb01353.x – volume: 21 start-page: 319 year: 2014 ident: 429_CR16 publication-title: Chem Biol doi: 10.1016/j.chembiol.2013.12.016 – volume: 37 start-page: 239 year: 2013 ident: 429_CR44 publication-title: Am J Nephrol doi: 10.1159/000346846 – volume: 15 start-page: 1316 year: 2013 ident: 429_CR26 publication-title: Cell Cycle doi: 10.4161/cc.24445 – volume: 101 start-page: 2454 year: 2003 ident: 429_CR118 publication-title: Blood doi: 10.1182/blood-2002-07-1984 – volume: 142 start-page: 482 year: 2012 ident: 429_CR8 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.11.040 – volume: 12 start-page: 553 year: 2002 ident: 429_CR67 publication-title: Eur J Dermatol – volume: 42 start-page: 361 issue: 3 year: 2014 ident: 429_CR128 publication-title: Drug Metab Dispos doi: 10.1124/dmd.113.055673 – volume: 37 start-page: 271 year: 1994 ident: 429_CR108 publication-title: J Neurosci Res doi: 10.1002/jnr.490370212 – volume: 39 start-page: 2611 year: 2008 ident: 429_CR121 publication-title: Stroke doi: 10.1161/STROKEAHA.107.513655 – volume: 70 start-page: 243 year: 1999 ident: 429_CR65 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/S0960-0760(99)00112-0 – volume: 85 start-page: 255 year: 2007 ident: 429_CR154 publication-title: J Neurooncol doi: 10.1007/s11060-007-9418-z – volume: 16 start-page: 1 year: 2010 ident: 429_CR152 publication-title: Cancer J doi: 10.1097/PPO.0b013e3181c51ee6 – volume: 88 start-page: 286 year: 2003 ident: 429_CR75 publication-title: J Cell Biochem doi: 10.1002/jcb.10346 – volume: 66 start-page: S73 year: 2008 ident: 429_CR39 publication-title: Nutr Rev doi: 10.1111/j.1753-4887.2008.00105.x – volume: 28 start-page: 385 year: 2006 ident: 429_CR167 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2006.04.033 – volume: 121 start-page: 408 year: 2010 ident: 429_CR78 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2010.03.053 – volume: 133 start-page: 120 year: 1999 ident: 429_CR170 publication-title: J Lab Clin Med doi: 10.1016/S0022-2143(99)90004-5 – volume: 29 start-page: S22 issue: Suppl. 29 year: 1990 ident: 429_CR21 publication-title: Kidney Int – volume: 37 start-page: 115 issue: 2 year: 2009 ident: 429_CR70 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2009.01.006 – volume: 130 start-page: 2464 year: 2012 ident: 429_CR112 publication-title: Int J Cancer doi: 10.1002/ijc.26279 – volume: 56 start-page: 830 year: 2011 ident: 429_CR81 publication-title: Dig Dis Sci doi: 10.1007/s10620-010-1544-3 – volume: 38 start-page: 1732 year: 2015 ident: 429_CR169 publication-title: Biol Pharm Bull doi: 10.1248/bpb.b15-00356 – volume: 116 start-page: 3294 year: 2010 ident: 429_CR85 publication-title: Cancer doi: 10.1002/cncr.25059 – volume: 141 start-page: 274 year: 1999 ident: 429_CR9 publication-title: Br J Dermatol doi: 10.1046/j.1365-2133.1999.02975.x – volume: 26 start-page: 852 year: 1995 ident: 429_CR141 publication-title: Am J Kidney Dis doi: 10.1016/0272-6386(95)90455-7 – volume: 5 start-page: 2502 year: 2013 ident: 429_CR123 publication-title: Nutrients doi: 10.3390/nu5072502 – volume: 111 start-page: 7 year: 2010 ident: 429_CR12 publication-title: J Cell Biochem doi: 10.1002/jcb.22661 – volume: 51 start-page: 741 issue: 5 year: 1997 ident: 429_CR132 publication-title: Mol Pharmacol doi: 10.1124/mol.51.5.741 – volume: 65 start-page: 720 issue: 3 year: 2004 ident: 429_CR45 publication-title: Mol Pharmacol doi: 10.1124/mol.65.3.720 – volume: 16 start-page: 618 year: 2007 ident: 429_CR126 publication-title: Exp Dermatol doi: 10.1111/j.1600-0625.2007.00570.x – volume: 110 start-page: 1605 year: 1996 ident: 429_CR68 publication-title: Gastroenterology doi: 10.1053/gast.1996.v110.pm8613068 – volume: 143 start-page: 1625 year: 2002 ident: 429_CR116 publication-title: Endocrinology doi: 10.1210/endo.143.5.8777 – volume: 231 start-page: 517 issue: 3 year: 1995 ident: 429_CR23 publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1995.tb20727.x – volume: 27 start-page: 1037 year: 2012 ident: 429_CR115 publication-title: J Korean Med Sci doi: 10.3346/jkms.2012.27.9.1037 – volume: 44 start-page: 1431 issue: 8 year: 2016 ident: 429_CR10 publication-title: Drug Metab Dispos doi: 10.1124/dmd.116.070300 – volume: 5 start-page: 213 year: 2014 ident: 429_CR106 publication-title: Front Physiol doi: 10.3389/fphys.2014.00213 – volume: 32 start-page: S61 year: 1998 ident: 429_CR94 publication-title: Am J Kidney Dis doi: 10.1053/ajkd.1998.v32.pm9808145 – volume: 139 start-page: 1197 year: 1998 ident: 429_CR173 publication-title: Endocrinology doi: 10.1210/endo.139.3.5770 – volume: 127 start-page: 748 year: 2007 ident: 429_CR18 publication-title: J Invest Dermatol doi: 10.1038/sj.jid.5700692 – volume: 1 start-page: 1 year: 1996 ident: 429_CR64 publication-title: J Investig Dermatol Symp Proc – volume: 97 start-page: 230 year: 1991 ident: 429_CR100 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12480255 – volume: 136 start-page: 83 year: 2013 ident: 429_CR103 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2013.02.005 – volume: 278 start-page: 48030 year: 2003 ident: 429_CR66 publication-title: J Biol Chem doi: 10.1074/jbc.M308430200 – volume: 276 start-page: 26365 year: 2001 ident: 429_CR97 publication-title: J Biol Chem doi: 10.1074/jbc.M010101200 – volume: 54 start-page: 383 year: 2015 ident: 429_CR144 publication-title: Int J Dermatol doi: 10.1111/ijd.12790 – volume: 33 start-page: 713 year: 2012 ident: 429_CR138 publication-title: Pediatr Cardiol doi: 10.1007/s00246-012-0199-6 – volume: 330 start-page: 389 year: 2009 ident: 429_CR48 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.149815 – volume: 93 start-page: 2225 year: 1999 ident: 429_CR104 publication-title: Blood doi: 10.1182/blood.V93.7.2225 – volume: 29 start-page: 691 year: 2009 ident: 429_CR109 publication-title: Pharmacotherapy doi: 10.1592/phco.29.6.691 – volume: 50 start-page: 999 year: 1997 ident: 429_CR53 publication-title: Urology doi: 10.1016/S0090-4295(97)00408-1 – volume: 26 start-page: 37 year: 2012 ident: 429_CR98 publication-title: Mol Endocrinol doi: 10.1210/me.2011-1109 – volume: 89 start-page: 182 year: 1997 ident: 429_CR22 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/89.3.182 – volume: 44 start-page: 693 year: 1992 ident: 429_CR35 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(92)90405-8 – volume: 9 start-page: 238 year: 2005 ident: 429_CR147 publication-title: Clin Exp Nephrol doi: 10.1007/s10157-005-0363-x – volume: 103 start-page: 521 year: 2007 ident: 429_CR140 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2006.12.098 – volume: 25 start-page: 130 year: 2007 ident: 429_CR52 publication-title: J Bone Miner Metab doi: 10.1007/s00774-006-0738-4 – volume: 134 start-page: 238 year: 1996 ident: 429_CR119 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.1996.tb07608.x – volume: 144 start-page: 500 year: 2001 ident: 429_CR43 publication-title: Br J Dermatol doi: 10.1046/j.1365-2133.2001.04075.x – volume: 2 start-page: 9 year: 2014 ident: 429_CR60 publication-title: Ann Transl Med – volume: 1 start-page: 97 year: 1996 ident: 429_CR89 publication-title: J Investig Dermatol Symp Proc – volume: 20 start-page: 147 year: 2014 ident: 429_CR95 publication-title: Mult Scler doi: 10.1177/1352458513494959 – volume: 324 start-page: 23 year: 2008 ident: 429_CR38 publication-title: Pharmacol Exp Ther doi: 10.1124/jpet.107.127209 – volume: 97 start-page: 93 year: 2005 ident: 429_CR153 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2005.06.002 – volume: 6 start-page: 727 year: 1997 ident: 429_CR134 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 262 start-page: 2536 year: 1987 ident: 429_CR157 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)61537-6 – volume: 76 start-page: 1017 year: 1997 ident: 429_CR36 publication-title: Br J Cancer doi: 10.1038/bjc.1997.501 – volume: 79 start-page: 1706 year: 1987 ident: 429_CR162 publication-title: J Clin Invest doi: 10.1172/JCI113010 – volume: 277 start-page: 25125 issue: 28 year: 2002 ident: 429_CR42 publication-title: J Biol Chem doi: 10.1074/jbc.M201323200 – volume: 20 start-page: 239 year: 2009 ident: 429_CR2 publication-title: Osteoporos Int doi: 10.1007/s00198-008-0650-y – volume: 79 start-page: 362 year: 2004 ident: 429_CR63 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/79.3.362 – volume: 133 start-page: 2724 year: 1993 ident: 429_CR107 publication-title: Endocrinology doi: 10.1210/endo.133.6.8243296 – volume: 79 start-page: 360 year: 2011 ident: 429_CR143 publication-title: Mol Pharmacol doi: 10.1124/mol.110.068403 – volume: 6 start-page: 284 year: 1996 ident: 429_CR50 publication-title: Osteoporos Int doi: 10.1007/BF01623386 – volume: 30 start-page: 457 year: 2009 ident: 429_CR27 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.682 – volume: 253 start-page: E675 year: 1987 ident: 429_CR161 publication-title: Am J Physiol – volume: 17 start-page: 41 issue: suppl 10 year: 2002 ident: 429_CR62 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/17.suppl_10.41 – volume: 26 start-page: 429 year: 2005 ident: 429_CR105 publication-title: Carcinogenesis doi: 10.1093/carcin/bgh332 – volume: 46 start-page: 149 year: 2012 ident: 429_CR88 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2012.02.018 – volume: 337 start-page: 846 year: 2011 ident: 429_CR29 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.111.179101 – volume: 90 start-page: 196 year: 1991 ident: 429_CR111 publication-title: Contrib Nephrol doi: 10.1159/000420143 – volume: 55 start-page: 821 year: 1999 ident: 429_CR102 publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.055003821.x – volume: 5 start-page: 122 year: 2014 ident: 429_CR82 publication-title: Front Physiol doi: 10.3389/fphys.2014.00122 – volume: 95 start-page: 896 year: 2003 ident: 429_CR76 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/95.12.896 – volume: 5 start-page: 187 year: 2012 ident: 429_CR120 publication-title: Ther Adv Neurol Disord doi: 10.1177/1756285612447090 – volume: 63 start-page: 2020 year: 2003 ident: 429_CR142 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00029.x – volume: 41 start-page: S108 year: 2003 ident: 429_CR168 publication-title: Am J Kidney Dis doi: 10.1053/ajkd.2003.50097 – volume: 55 start-page: 455 issue: 3 year: 2014 ident: 429_CR25 publication-title: J Lipid Res doi: 10.1194/jlr.M044420 – volume: 40 start-page: 265 year: 2013 ident: 429_CR1 publication-title: J Rheumatol doi: 10.3899/jrheum.111594 – volume: 166 start-page: 91 year: 2015 ident: 429_CR41 publication-title: Int Arch Allergy Immunol doi: 10.1159/000371350 – volume: 9 start-page: 1427 year: 1998 ident: 429_CR93 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V981427 – volume: 60 start-page: 1399 year: 2001 ident: 429_CR149 publication-title: Mol Pharmacol doi: 10.1124/mol.60.6.1399 – volume: 83 start-page: 754 year: 2006 ident: 429_CR131 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/83.4.754 – volume: 103 start-page: 3793 year: 2014 ident: 429_CR71 publication-title: J Pharm Sci doi: 10.1002/jps.24195 – volume: 141 start-page: 2043 year: 2000 ident: 429_CR130 publication-title: Endocrinology doi: 10.1210/endo.141.6.7515 – volume: 5 start-page: 447 year: 2006 ident: 429_CR171 publication-title: Cell Cycle doi: 10.4161/cc.5.4.2467 – volume: 32 start-page: 112 year: 2011 ident: 429_CR87 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.742 – volume: 56 start-page: 383 year: 1999 ident: 429_CR129 publication-title: Kidney Int doi: 10.1046/j.1523-1755.1999.00575.x – volume: 28 start-page: 1877 year: 2007 ident: 429_CR3 publication-title: Carcinogenesis doi: 10.1093/carcin/bgm094 – volume: 15 start-page: 301 year: 2004 ident: 429_CR127 publication-title: Osteoporos Int doi: 10.1007/s00198-003-1570-5 – volume: 179 start-page: 57 year: 1991 ident: 429_CR37 publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(91)91333-8 – volume: 160 start-page: 247 year: 1998 ident: 429_CR51 publication-title: J Urol doi: 10.1016/S0022-5347(01)63098-2 – volume: 85 start-page: 198 issue: 2 year: 2009 ident: 429_CR133 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.165 – volume: 8 start-page: 480 year: 2004 ident: 429_CR6 publication-title: Ther Apher Dial doi: 10.1111/j.1774-9987.2004.00191.x – volume: 5 start-page: 244 year: 2014 ident: 429_CR165 publication-title: Front Physiol – volume: 3 start-page: 180 year: 2011 ident: 429_CR151 publication-title: Dermatoendocrinol doi: 10.4161/derm.17534 – volume: 280 start-page: 12 year: 2015 ident: 429_CR4 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2015.01.005 – volume: 288 start-page: E125 year: 2005 ident: 429_CR166 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00224.2004 – volume: 65 start-page: 705 year: 2004 ident: 429_CR150 publication-title: Kidney Int doi: 10.1111/j.1523-1755.2004.00432.x – volume: 157 start-page: 168 year: 2012 ident: 429_CR13 publication-title: Int Arch Allergy Immunol doi: 10.1159/000323941 – volume: 69 start-page: 1913 year: 2006 ident: 429_CR24 publication-title: Mol Pharmacol doi: 10.1124/mol.105.020792 – volume: 14 start-page: 2975 year: 2003 ident: 429_CR46 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000093255.56474.B4 – volume: 103 start-page: 533 year: 2007 ident: 429_CR110 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2006.12.099 – volume: 69 start-page: 1740 year: 2006 ident: 429_CR174 publication-title: Mol Pharmacol doi: 10.1124/mol.105.019851 – volume: 122 start-page: 1357 year: 2004 ident: 429_CR7 publication-title: Arch Ophthalmol doi: 10.1001/archopht.122.9.1357 – volume: 26 start-page: 543 year: 2012 ident: 429_CR72 publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2011.00944.x – volume: 6 start-page: 468 year: 2010 ident: 429_CR137 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.86 – volume: 3 start-page: 373 year: 2004 ident: 429_CR11 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.373.3.3 – volume: 59 start-page: 24 issue: Suppl 1 year: 2000 ident: 429_CR80 publication-title: Z Rheumatol doi: 10.1007/s003930070034 – volume: 82 start-page: 37 year: 2012 ident: 429_CR47 publication-title: Mol Pharmacol doi: 10.1124/mol.112.077909 – volume: 43 start-page: 877 issue: 5 year: 2004 ident: 429_CR33 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2004.01.012 – volume: 8 start-page: 1787 year: 2009 ident: 429_CR15 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-09-0064 – volume: 146 start-page: 414 year: 2002 ident: 429_CR156 publication-title: Br J Dermatol doi: 10.1046/j.1365-2133.2002.04567.x – volume: 178 start-page: 54 year: 2016 ident: 429_CR160 publication-title: Transl Res doi: 10.1016/j.trsl.2016.07.006 – volume: 27 start-page: 4467 year: 2008 ident: 429_CR117 publication-title: Oncogene doi: 10.1038/onc.2008.88 – volume: 133 start-page: 2425S year: 2003 ident: 429_CR164 publication-title: J Nutr doi: 10.1093/jn/133.7.2425S – volume: 1 start-page: 667 year: 2002 ident: 429_CR58 publication-title: Mol Cancer Ther – volume: 69 start-page: 967 year: 2009 ident: 429_CR32 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2307 – volume: 56 start-page: 264 year: 1996 ident: 429_CR158 publication-title: Cancer Res – volume: 21 start-page: 321 year: 2001 ident: 429_CR59 publication-title: Anticancer Res – volume: 17 start-page: 1313 year: 2002 ident: 429_CR90 publication-title: Science doi: 10.1126/science.1070477 – volume: 116 start-page: 5535 year: 2010 ident: 429_CR136 publication-title: Cancer doi: 10.1002/cncr.25478 – volume: 122 start-page: 984 year: 2004 ident: 429_CR17 publication-title: J Invest Dermatol doi: 10.1111/j.0022-202X.2004.22424.x – volume: 258 start-page: E134 year: 1990 ident: 429_CR163 publication-title: Am J Physiol – volume: 31 start-page: 91 year: 2010 ident: 429_CR28 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.694 – volume: 20 start-page: 1742 year: 2005 ident: 429_CR69 publication-title: J Bone Miner Res doi: 10.1359/JBMR.050605 – volume: 7 start-page: 430 year: 2008 ident: 429_CR135 publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.3.5418 – volume: 119 start-page: 223 year: 1988 ident: 429_CR73 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.1988.tb03204.x – volume: 39 start-page: 99 year: 2018 ident: 429_CR124 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.2118 – volume: 4 start-page: 827 year: 2008 ident: 429_CR146 publication-title: Ther Clin Risk Manag doi: 10.2147/TCRM.S3552 – volume: 280 start-page: 23232 issue: 24 year: 2005 ident: 429_CR96 publication-title: J Biol Chem doi: 10.1074/jbc.M411520200 – volume: 4 start-page: 11 year: 2004 ident: 429_CR79 publication-title: Exp Dermatol 13 Suppl doi: 10.1111/j.1600-0625.2004.00257.x – volume: 87 start-page: 214 year: 2000 ident: 429_CR91 publication-title: Circ Res doi: 10.1161/01.RES.87.3.214 – volume: 17 start-page: 28 issue: Suppl. 10 year: 2002 ident: 429_CR5 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/17.suppl_10.28 – volume: 117 start-page: 503 year: 2008 ident: 429_CR159 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.706127 – volume: 1 start-page: iii2 issue: Suppl 3 year: 2008 ident: 429_CR55 publication-title: NDT Plus – volume: 48 start-page: 351 year: 2013 ident: 429_CR99 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2012.11.008 – volume: 3 start-page: 237 year: 2013 ident: 429_CR172 publication-title: Eur J Microbiol Immunol (Bp) doi: 10.1556/EuJMI.3.2013.4.1 – volume: 12 start-page: 463 year: 2002 ident: 429_CR101 publication-title: Eur J Dermatol – volume: 103 start-page: 416 year: 2007 ident: 429_CR125 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2006.12.081 – volume: 337 start-page: 193 year: 1991 ident: 429_CR74 publication-title: Lancet doi: 10.1016/0140-6736(91)92157-W – volume: 164 start-page: 133 year: 2000 ident: 429_CR145 publication-title: Mol Cell Endocrinol doi: 10.1016/S0303-7207(00)00226-4 – volume: 279 start-page: 25260 year: 2004 ident: 429_CR83 publication-title: J Biol Chem doi: 10.1074/jbc.M311052200 |
SSID | ssj0000561889 |
Score | 2.178397 |
SecondaryResourceType | review_article |
Snippet | Vitamin D is involved in retaining the balance of several minerals in the body, such as calcium and phosphate, which are crucial for the bone formation and... |
SourceID | nrf crossref springer |
SourceType | Open Website Enrichment Source Index Database Publisher |
StartPage | 1 |
SubjectTerms | Biomedical and Life Sciences Biomedicine Review 약학 |
Title | Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes |
URI | https://link.springer.com/article/10.1007/s40005-019-00429-z https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002552342 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Pharmaceutical Investigation, 2020, 50(1), , pp.1-16 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Pb9MwFLZod-ECTIAoPyZr4gaeiB3HzrECxgaCUyuNk_Xi2FPVNq3aDGn9B_i3eXacTsA0aZfkkmcltvP8ffZ73yPkba0UlBJKVnHvWC4-ACsFcIbEx2tAwKFi-tj3H8XZNP96IS9SUti2j3bvjySjp94nu-UBXyD1LVn0omw3IAcy06UekoPxl5_fbvZWAirWsfodR8LOpJQ85cvc3tBfa9Kg2fj_jkXjanP6mEz79-yCTOYnV211Ynf_SDje90OekEcJftJxN18OyQPXPCW_JzdJWLQLDd_Slae_Zi0sZw39RNEtujWyc7qYXYbcYIoXGs8Y6DppX88Rrgb7FCBCq2u6XNWpOFhord3LqG86-6VrcQYugk2zu1667TMyOf08-XjGUoEGZgWXLasBeKGKLANfWQ9a1w7pXAbCFhxKXVufW4UuxWlnhdWZKiqhvMitLEBKEM_JsFk17gWh3EsONWKzkIerPYCypcgKiwTd2RLqEcn6ETI2iZeHGhoLs5ddjr1qsFdN7FWzG5F3e5t1J91x59PHOPBmbmcmKG6H--XKzDcGecW5KYKMvxIj8r4fUpP-9e0dbb683-OvyEMe2Hzc4HlNhu3myr1ByNNWR2mGH5HBlI__AEJS-nM |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NbxMxELVoOMClagWIUEotxA0ssfZ67T1GLVECbU-p1Js167WrKMkmSpZKzR_o32bsOIsQqBKX3YvHh_HXe_a8GUI-1UpBKaFkFfeO5eIrsFIAZ0h8vAYEHCrKx66ui9FN_v1W3iZR2GYf7b5_kow7dSd2ywO-QOpbsriLsu0BeY5gQIe6BTd80N2sBEysY-07jnSdSSl5Usv8u5s_TqSDZu3_ehSNZ83wiBwmkEgHu1E9Js9c84o8Tn5LpegugHtDl57eI7tfTBt6QXHzcivk0HQ-vQsKXoofGl8C6CplqJ4hqAz2KYyDVg90saxTCa_QW9slO1_v7BeuxXkyDzbN9mHhNq_JZPhtcj5iqYwCs4LLltUAvFBFloGvrAeta4ekKwNhCw6lrq3PrcKF77SzwupMFZVQXuRWFiAliDek1ywb95ZQ7iWHGhFUUMtqD6BsKbLCIo12toS6T7K9J41NKcZDpYu56ZIjR-8b9L6J3jfbPvnc2ax2CTaebP0RB8jM7NSEvNjhf7c0s7VB9D82RUi2r0SffNmPn0krcvNEn-_-r_kZeTGaXF2ay_H1jxPykgf-Ha9k3pNeu_7pThGktNWHOCd_AWP53zM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT-MwELX4kBAXxArQFthdC-0NLDZ2HCdHBFvxrT0UiZs1cWxUtU2rNiDRP8Df3rGThkWLkLgkF48PY3s8z_Z7Q8jPQinIJGQs586yWPwClgngDIGPSwETDhXoYze3yfldfHkv7_9h8YfX7osryZrT4FWayup4UrjjlvgW-1wDYXDGQkRl82WyiuE48jP9jp-0pyw-P05DHTyO0J1JKXnDnHm_mze703I5df9dkIZ9p7tJNpqEkZ7UI_yFLNlyi7z0XmlTtH7MPaNjR58Q6Y_6JT2jGMjsBPE0HfYfPJuX4oeGWwE6adSqB5hgevvmSQfNn-loXDTlvHxvVSt8Pq3tR7bCOTP0NuX8eWRn26TX_d07PWdNSQVmBJcVKwB4opIoApcbB2laWARgEQiTcMjSwrjYKAwCNrVGmDRSSS6UE7GRCUgJYoeslOPSfiWUO8mhwGzKM2dTB6BMJqLEIKS2JoOiQ6KFJ7Vp5MZ91YuhboWSg_c1el8H7-t5hxy2NpNabOPD1gc4QHpg-tprZPv_w1gPphqRwIVOvPC-Eh1ytBg_3azO2Qd97n6u-Q-y9uesq68vbq_2yDr3UDyczuyTlWr6aL9hvlLl38OU_As1SuNv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Therapeutic+targets+of+vitamin+D+receptor+ligands+and+their+pharmacokinetic+effects+by+modulation+of+transporters+and+metabolic+enzymes&rft.jtitle=Journal+of+pharmaceutical+investigation&rft.au=Choi%2C+Min+Sik&rft.au=Kim%2C+Yu+Chul&rft.au=Maeng%2C+Han-Joo&rft.date=2020-01-01&rft.issn=2093-5552&rft.eissn=2093-6214&rft.volume=50&rft.issue=1&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1007%2Fs40005-019-00429-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40005_019_00429_z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-5552&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-5552&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-5552&client=summon |